NewsBenzinga미국 판사, 일라이 릴리의 체중 감량 약 광고 지속 허용···노보 노디스크에 불리한 판결 미국 판사, 일라이 릴리의 체중 감량 약 광고 지속 허용···노보 노디스크에 불리한 판결 Benzinga 2026.10.26 19:59 (GMT+0) Open on Benzinga Other news Canaccord Genuity Maintains Buy on Belite Bio, Raises Price Target to $314 Applied Optoelectronics Stock Sinks Amid AI Outlook Fears Canaccord Genuity Maintains Buy on Enovix, Lowers Price Target to $2.5 Canaccord Genuity Maintains Buy on Intuitive Machines, Lowers Price Target to $38 'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report Canaccord Genuity Maintains Buy on Nektar Therapeutics, Lowers Price Target to $149
'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report